|
SPIN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74082970261225E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.18940446170291E-11 |
| Normal-vs-Stage2 |
2.87229999995642E-06 |
| Normal-vs-Stage3 |
6.70139499447941E-11 |
| Normal-vs-Stage4 |
1.71739999998977E-09 |
| Stage1-vs-Stage2 |
7.852600E-01 |
| Stage1-vs-Stage3 |
1.557990E-01 |
| Stage1-vs-Stage4 |
8.910200E-02 |
| Stage2-vs-Stage3 |
2.204000E-01 |
| Stage2-vs-Stage4 |
1.043830E-01 |
| Stage3-vs-Stage4 |
5.685600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.42867964522975E-13 |
| Normal-vs-AfricanAmerican |
2.35690000000011E-05 |
| Normal-vs-Asian |
4.29229999999725E-05 |
| Caucasian-vs-AfricanAmerican |
7.624000E-01 |
| Caucasian-vs-Asian |
1.519960E-01 |
| AfricanAmerican-vs-Asian |
2.372800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31480004661455E-09 |
| Normal-vs-Female |
1.96687111042593E-12 |
| Male-vs-Female |
5.671000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.5616000149119E-09 |
| Normal-vs-Age(41-60Yrs) |
2.23139950961126E-10 |
| Normal-vs-Age(61-80Yrs) |
4.75130002008939E-09 |
| Normal-vs-Age(81-100Yrs) |
1.241750E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.786600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.607000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.139000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.376600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.385200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.453200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.003860E-04 |
| Classical-VS-Follicular |
2.275400E-01 |
| Classical-VS-Other |
4.037800E-01 |
| Classical-VS-Normal |
3.53579999723408E-08 |
| Tall-VS-Follicular |
6.13579999999558E-05 |
| Tall-VS-Other |
8.984100E-02 |
| Tall-VS-Normal |
5.42055289542986E-12 |
| Follicular-VS-Other |
7.644000E-01 |
| Follicular-VS-Normal |
1.96814999999795E-05 |
| Other-VS-Normal |
9.771800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.82800002807215E-09 |
| Normal-vs-N1 |
1.40299999951132E-07 |
| N0-vs-N1 |
3.003000E-01 |
|
|
